Ledger.Open graph →
SEC Form D · filed October 21, 2009

BELLICUM PHARMACEUTICALS, INC

Offering
$2.5M
Sold
$1.3M
Exemption
—
Industry
Pharmaceuticals
Location
HOUSTON, TX
Type
—

People & firms on this filing (8)

David Spencer · Houston, TXExecThomas Farrell · Houston, TXExec · DirectorKevin Slawin · Houston, TXExec · DirectorFrank Mcguyer · Houston, TXDirectorTimothy P. Faenza · New York, NYExec · DirectorWilliam L. Edwards · Palo Alto, CAExec · DirectorMark Shamia · Palo Alto, CAExecRobert E. Mckee, Iii · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗